Abbott has been laid off, nearly two hundred people have been laid off

  • time:
  • Views: 167
  • Source: Dongyang Information Network

    Summary: Abbott revealed that the layoffs were adjusted by the outsourcer? It's normal for foreign companies to sell products as a whole

    (Original title: Abbott reveals that the layoffs are adjusted by the outsourcer? The entire group of layoffs sold by foreign companies has become the norm.)

    Abbott lays off nearly two hundred people! Is it difficult to pass the year? Yesterday, Abbott responded to the Guangzhou Daily and said, "China is an important market for Abbott. We are full of confidence in the Chinese market and continue to invest in business development. Internal management service providers are not allowed to adjust their own resources. Comment. "Although not, it is" common "for foreign-funded pharmaceutical companies to lay off employees.

    Our reporter observed that in recent years, foreign-funded pharmaceutical companies have sold products and laid off entire groups of employees.

    News of layoffs in the Chinese market include well-known pharmaceutical companies such as Roche, Sanofi, UBS, GlaxoSmithKline, Bristol-Myers Squibb, Boehringer Ingelheim and others. Earlier, Ushibee notified in a conference call that, since 2017, Pan-FuShu has outsourced sales to Shanghai Sima Kang Biotechnology Co., Ltd .; and a district of GlaxoSmithKline has just started layoffs to "integrate In addition, Bristol-Myers Squibb also recently denied dissolution of its OTC business and its team; Boehringer Ingelheim also outsourced each business to a domestic company.

    "Foreign pharmaceutical companies have been cultivating in China for many years, and the earlier the expansion was, the faster it is now because of the expiry of pharmaceutical patents, the tightening of anti-corruption in Chinese medicine, the temporary absence of new drugs, and the lack of product development. Each team has become commonplace in the industry. "An industry observer said that the termination of non-prescription drug products in the Chinese market to actively promote foreign companies is indeed a difficult decision, but for multinational pharmaceutical companies, layoffs and focus on key businesses are For the sake of cost control, cutting off the production line with poor profitability helps to "go light". I feel that it is necessary for foreign companies to adjust their directions to adapt to the new environment of the Chinese market.

    • No fake Abbott and Bein beauty milk powder have been found in Yinchuan
    • Hong Kong version of Meisu milk powder, Hong Kong version of Abbott milk powder baby care experts expressed trust